Dive into the archives.
- Hot off the ENS Press: Immunomodulatory Treatment Improves Cognitive Function in PWMS
By Judith Moser, MD MILAN, Italy — June 26, 2009 — Patients with relapsing-remitting multiple sclerosis (RRMS) who receive glatiramer acetate (GA) or interferon (IFN) beta show a reduction in cognitive impairment and relative stability of cognitive and affective variables at 2 years, according to the results of an observational study presented here at the [...]
